On June 24, Nektar Therapeutics announced positive results from its mid-stage REZOLVE-AD study for rezpegaldesleukin, which is an eczema treatment.

Hand eczema can cause a reduction in quality of life leading to many work-related problems. Various types of hand eczema exist, and different topical (creams, ointments, or lotions) and systemic ...

Eating gluten may worsen eczema symptoms in people with a gluten-related disorder, such as celiac disease. However, more research is needed to fully understand the link between gluten and eczema.

9 Ways to Prevent Atopic Dermatitis (Eczema) Flares in Cold Weather Dry air and temperature swings can be hard on your skin, especially when you have atopic dermatitis.

Eczema is a common chronic skin condition. Probiotics have been proposed as an effective treatment for eczema; their use is increasing, as numerous clinical trials are under way. This is an update of ...

Rezpegaldesleukin (Rezpeg) shows fast, effective eczema relief in Phase 2 trial with fewer side effects than other treatments, offering hope for moderate-to-severe cases.

Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of clear differentiation” for rezpegaldesleukin in the atopic dermatitis space.

Nektar reported positive Phase 2b trial data for rezpegaldesleukin in atopic dermatitis, showing strong efficacy and a consistent safety profile.

Nektar (NKTR) stock more than doubles as its eczema drug hits key targets in Phase 2b trial, promising new biology in autoimmune treatment.

FDA investigating Elevidys safety; Nektar shares spike on eczema data The agency said it will evaluate whether further regulatory action is needed after investigating the deaths of two patients ...